Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jul 27, 2010

Premium

Alan Guttmacher has been appointed as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, an institute of the National Institutes of Health. He has been NICHD's acting director since last December. Prior to that, he was acting director of the National Human Genome Research Institute, and before that, NHGRI's deputy director. He came to the NIH from the University of Vermont, where he directed the department of pediatrics' Vermont Regional Genetics Center and pregnancy risk information service. Guttmacher holds degrees from Harvard College and Harvard Medical School.


Mason Morfit has been appointed to the board of directors of Immucor. He is a partner with ValueAct Capital, an investment management firm that is currently Immucor's largest shareholder. Morfit is a former director of Solexa. He holds a BA from Princeton University.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.